Press releases
- Revvity to Present at BofA Securities 2024 Health Care Conference
- Revvity Unveils a New Era of Automated Tuberculosis Testing
- Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners
- Revvity To Hold Earnings Call on Monday, April 29, 2024
- Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software
- Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group
- Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication
- Revvity to Present at Upcoming Investor Conferences
- Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions
- Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023
More ▼
Key statistics
On Thursday, Revvity Inc (0KHE:LSE) closed at 101.45, 27.61% above the 52 week low of 79.50 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 102.21 |
Average volume | 124.71 |
---|---|
Shares outstanding | 123.52m |
Free float | 123.18m |
P/E (TTM) | 71.27 |
Market cap | 12.68bn USD |
EPS (TTM) | 1.44 USD |
Annual div (ADY) | 0.28 USD |
---|---|
Annual div yield (ADY) | 0.27% |
Div ex-date | Apr 18 2024 |
Div pay-date | May 10 2024 |
Data delayed at least 20 minutes, as of Apr 25 2024 15:32 BST.
More ▼